A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2).

Coghi, Paolo; Yang, Li Jun; Ng, Jerome P L; Haynes, Richard K; Memo, Maurizio; Gianoncelli, Alessandra; Wong, Vincent Kam Wai; Ribaudo, Giovanni

Coghi, Paolo; Yang, Li Jun; Ng, Jerome P L; Haynes, Richard K; Memo, Maurizio; Gianoncelli, Alessandra; Wong, Vincent Kam Wai; Ribaudo, Giovanni.

Afiliação

Coghi P; School of Pharmacy, Macau University of Science and Technology, Taipa 999078, China.
Yang LJ; Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa 999078, China.
Ng JPL; Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa 999078, China.
Haynes RK; Center of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University Potchefstroom, Potchefstroom 2531, South Africa.
Memo M; Department of Molecular and Translational Medicine, University of Brescia, 25121 Brescia, Italy.
Gianoncelli A; Department of Molecular and Translational Medicine, University of Brescia, 25121 Brescia, Italy.
Wong VKW; Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa 999078, China.
Ribaudo G; Department of Molecular and Translational Medicine, University of Brescia, 25121 Brescia, Italy.

Pharmaceuticals (Basel) ; 14(10)2021 Sep 23.

Article em En | MEDLINE | ID: mdl-34681178